Literature DB >> 29157619

Diagnosis of Castleman Disease.

Raphaël Szalat1, Nikhil C Munshi2.   

Abstract

Castleman disease (CD) is a rare and heterogenous group of disorders sharing in common an abnormal lymph node pathology. CD comprises distinct subtypes with different prognoses. Unicentric CD and multicentric CD are featured by specific systemic manifestations and may be associated with Kaposi sarcoma, non-Hodgkin and Hodgkin lymphoma, and POEMS syndrome. Multicentric CD is classically associated with systemic symptoms and poorer prognosis. In this article, the authors review how to diagnose the disease, keeping in context the clinical findings, biochemical changes and complications associated with CD.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Castleman disease; Diagnosis; HHV8; POEMS; Paraneoplastic pemphigus; TAFRO

Mesh:

Year:  2018        PMID: 29157619     DOI: 10.1016/j.hoc.2017.09.005

Source DB:  PubMed          Journal:  Hematol Oncol Clin North Am        ISSN: 0889-8588            Impact factor:   3.722


  12 in total

1.  A mesorectal incidentaloma: Rare localization of Castleman disease (Case report).

Authors:  Daniel Ion; Alexandra Bolocan; Alexandru George Filipescu; Octavian Andronic; Ana-Maria Oproiu; Adelina Popa; Dan Nicoale Păduraru
Journal:  Exp Ther Med       Date:  2022-02-08       Impact factor: 2.447

2.  Castleman's disease in the pelvic retroperitoneum: A case report.

Authors:  Qingli Zhao; Xuebei Zhang; Xiaoqing Yang; Shengliang Huang
Journal:  Exp Ther Med       Date:  2022-09-07       Impact factor: 2.751

3.  Comprehensive analysis of 65 patients with Castleman disease in a single center in China.

Authors:  Xi-Qian Wang; Nian-Nian Zhong; Qi Sun; Si-Chen Yan; Guang-Cai Xu; Yong-Gong Wang; Li-Wei Peng; Bing Liu; Lin-Lin Bu
Journal:  Sci Rep       Date:  2022-05-24       Impact factor: 4.996

4.  Histologic and Laboratory Characteristics of Symptomatic and Asymptomatic Castleman Disease in the Pediatric Population.

Authors:  Karen M Chisholm; Mark D Fleming
Journal:  Am J Clin Pathol       Date:  2020-05-05       Impact factor: 2.493

Review 5.  Clinicopathological comparison and therapeutic approach to Castleman disease-a case-based review.

Authors:  Małgorzata Wojtyś; Agnieszka Piekarska; Michał Kunc; Konrad Ptaszyński; Wojciech Biernat; Jan Maciej Zaucha; Piotr Waloszczyk; Piotr Lisowski; Bartosz Kubisa; Tomasz Grodzki
Journal:  J Thorac Dis       Date:  2019-11       Impact factor: 2.895

6.  Clinical characteristics and prognosis of patients with Castleman disease in a Chinese hospital: paraneoplastic pemphigus is an independent risk factor.

Authors:  Yibo Hua; Chao Liang; Jie Yang; Luyang Wang; Aimin Xu; Lei Xi; Shangqian Wang; Zengjun Wang
Journal:  Am J Transl Res       Date:  2022-02-15       Impact factor: 4.060

Review 7.  Emerging role of 18F-FDG PET/CT in Castleman disease: a review.

Authors:  Benjamin Koa; Austin J Borja; Mahmoud Aly; Sayuri Padmanabhan; Joseph Tran; Vincent Zhang; Chaitanya Rojulpote; Sheila K Pierson; Mark-Avery Tamakloe; Johnson S Khor; Thomas J Werner; David C Fajgenbaum; Abass Alavi; Mona-Elisabeth Revheim
Journal:  Insights Imaging       Date:  2021-03-11

8.  A Rare Lymphoproliferative Disease: Castleman Disease

Authors:  Eren Gündüz; Nihal Özdemir; Şule Mine Bakanay; Sema Karakuş
Journal:  Turk J Haematol       Date:  2021-11-01       Impact factor: 1.831

9.  Castleman disease. Interaction with dermatopathy: Case report.

Authors:  M L A Modolin; C P Camargo; D A Milcheski; W Cintra; R I Rocha; G M Clivatti; B Nascimento; R Gemperli
Journal:  Int J Surg Case Rep       Date:  2020-07-18

Review 10.  Innate Immunity: A Common Denominator between Neurodegenerative and Neuropsychiatric Diseases.

Authors:  Fabiana Novellino; Valeria Saccà; Annalidia Donato; Paolo Zaffino; Maria Francesca Spadea; Marco Vismara; Biagio Arcidiacono; Natalia Malara; Ivan Presta; Giuseppe Donato
Journal:  Int J Mol Sci       Date:  2020-02-07       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.